Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer

Authors:

Abstract
Purpose: The prevalence and risk factors for thromboembolism (TE) in children with cancer are largely unknown. This retrospective cohort study aims to determine the epidemiology of TE and to identify potential risk factors for TE in children with cancer.Methods: We used logistic regression to determine the association of age (P < 0.001). Older patients had increased risk of developing TE compared to younger patients [Odds ratios (OR) 1.8; 95% CI; 1.0,3.2; P = 0.036]. Children with acute lymphoblastic leukemia (ALL) (OR 4.6; 95% CI; 1.8, 12.3; P = 0.002), lymphoma (OR 3.8; 95% CI; 1.3, 11.1; P = 0.016), and sarcoma (OR 4.3; 95% CI; 1.4, 13.3; P = 0.012) had an increased risk of TE. Subgroup analyses showed that patients with CVL‐dysfunction and intra‐thoracic disease had a higher prevalence of TE compared to those without CVL‐dysfunction (22.8% vs. 8.8%; 95% CI; 4.0, 24.3; P = 0.006) and intra‐thoracic disease (18.0% vs. 6.1%; 95% CI; 2.4, 21.4; P = 0.02).Conclusions: TE is common in children with cancer. Age and type of cancer are independent risk factors for TE in children with non‐CNS cancers. CVL‐dysfunction and intra‐thoracic disease are significantly associated with the diagnosis of TE. Pediatr Blood Cancer 2008;51:792–797.
Funding Information
  • Hamilton Health Science Foundation, Canada
  • Heart and Stroke Foundation of Canada (NA 6159)

This publication has 39 references indexed in Scilit: